Pagina blog
Update of authorized prescription centres
The list of centres authorized by the Italian regions to the prescription of drugs for the treatment of hepatitis C has been updated again.
Non compliance for an Indian manufacturing site
Following an inspection by the Portuguese Agency, the pharmaceutical manufacturing site Symed Labs Limited, Telangana, India resulted as not in compliance with the GMP.
Medical devices, new online database for the FDA
The regulatory agency FDA has launched a new online database that includes all guidelines pertaining to medical device manufacturers with products registered for sale in…
Resistance to antibiotics, Europe and the WHO identify objectives
The first data on the massive use of antibiotics in Europe is now available, which has the purpose of identifying the possible relationships between the…
First-class service at low cost, the WHO praises Singapore
During an official meeting, the Director-General of the WHO praised the national health system in Singapore, for being able to provide first-class health care at…
Hydroxyzine, EMA communication
The Pharmacovigilance Risk Assessment Committee (PRAC) of the EMA has concluded the evaluation of medicinal products based on hydroxyzine, an antihistamine approved in Europe for…
Pharmacovigilance, the international situation
An international meeting with the participation of European and African countries bordering the Mediterranean has been the occasion to take stock of the international situation…
Controversy over off-label use continues
The debate continues on off-label use, which is permitted by some governments for the sole purpose of reducing the costs of national health care.
The European monitoring project has been concluded
The European Medicines Agency has completed a major project that explored the possibilities of improving the evaluation of drugs in Europe.
Supplements, prohibitions, and maximum intakes
The Ministry of Health has set new limits and prohibitions on the use of substances in food supplements.
